Last --
Change Today 0.00 / 0.00%
Volume 0.0
2348 On Other Exchanges
Symbol
Exchange
2348 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kei Ling Li

Co-Founder, Chairman, Chairperson of Nomination Committee and Member of Remuneration Committee, Dawnrays Pharmaceutical Holdings Ltd.
AgeTotal Calculated CompensationThis person is connected to 7 board members in 1 different organizations across 1 different industries.

See Board Relationships
65CNY927,000
As of Fiscal Year 2013

Background*

Ms. Kei Ling Li is Co-Founder of Dawnrays Pharmaceutical Holdings Ltd. and served as its Head of Corporate Development. Ms. Li is responsible for the overall planning and implementation of corporate development, financial management and strategies formulation of the Dawnrays Pharmaceutical. Ms. Li has over 20 years of experience in corporate management in respect of strategic planning, business operations and finance, in particular for pharmaceutical enterprises in the ...

Read Full Background

Corporate Headquarters*

CNT Tower
Wanchai, -- --

Hong Kong

Phone: --
Fax: --

Board Members Memberships*

2002-Present
Co-Founder, Chairman, Chairperson of Nomination Committee and Member of Remuneration Committee

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

SalaryCNY873,000
Total Annual CompensationCNY873,000

Stock Options*

All Other CompensationCNY16,000

Total Compensation*

Total Annual Cash CompensationCNY927,000
Total Short Term CompensationCNY873,000
Other Long Term CompensationCNY16,000
Total Calculated CompensationCNY927,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
2348:HK $5.83 HKD +0.03

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAWNRAYS PHARMACEUTICAL HOLD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.